SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism

M. Svetel; A. Djarmati; N. Dragašević; D. Savić; B. Čuljković; S. Romac; V. S. Kostić

doi:10.1046/j.1468-1331.2003.00671.x

SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism

M. Svetel, A. Djarmati, N. Dragašević, D. Savić, B. Čuljković, S. Romac, V. S. Kostić^*

^*Corresponding author for this work

Institute of Neurogenetics

University of Belgrade

5 Citations (Scopus)

Abstract

In this study no one of our 85 patients of Serbian origin with young-onset (≤ 45 years) dopa-responsive parkinsonism (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar ataxia type 2 (SCA2) or SCA3 mutation. These data do not prove the significance of these two mutations in either sporadic or familial YOP suggestive of Parkinson's disease.

Original language	English
Journal	European Journal of Neurology
Volume	10
Issue number	5
ISSN	1351-5101
DOIs	https://doi.org/10.1046/j.1468-1331.2003.00671.x
Publication status	Published - 01.09.2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1046/j.1468-1331.2003.00671.x

Cite this

@article{c19dfb7479de4d9abc79b8b854062b1d,

title = "SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism",

abstract = "In this study no one of our 85 patients of Serbian origin with young-onset (≤ 45 years) dopa-responsive parkinsonism (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar ataxia type 2 (SCA2) or SCA3 mutation. These data do not prove the significance of these two mutations in either sporadic or familial YOP suggestive of Parkinson's disease.",

author = "M. Svetel and A. Djarmati and N. Draga{\v s}evi{\'c} and D. Savi{\'c} and B. {\v C}uljkovi{\'c} and S. Romac and Kosti{\'c}, \{V. S.\}",

year = "2003",

month = sep,

day = "1",

doi = "10.1046/j.1468-1331.2003.00671.x",

language = "English",

volume = "10",

journal = "European Journal of Neurology",

issn = "1351-5101",

publisher = "John Wiley and Sons Inc",

number = "5",

}

TY - JOUR

T1 - SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism

AU - Svetel, M.

AU - Djarmati, A.

AU - Dragašević, N.

AU - Savić, D.

AU - Čuljković, B.

AU - Romac, S.

AU - Kostić, V. S.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - In this study no one of our 85 patients of Serbian origin with young-onset (≤ 45 years) dopa-responsive parkinsonism (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar ataxia type 2 (SCA2) or SCA3 mutation. These data do not prove the significance of these two mutations in either sporadic or familial YOP suggestive of Parkinson's disease.

AB - In this study no one of our 85 patients of Serbian origin with young-onset (≤ 45 years) dopa-responsive parkinsonism (YOP), previously proved negative for PARK1 and PARK2 mutations, had either spinocerebellar ataxia type 2 (SCA2) or SCA3 mutation. These data do not prove the significance of these two mutations in either sporadic or familial YOP suggestive of Parkinson's disease.

UR - https://www.scopus.com/pages/publications/0142119362

U2 - 10.1046/j.1468-1331.2003.00671.x

DO - 10.1046/j.1468-1331.2003.00671.x

M3 - Journal articles

C2 - 12940846

AN - SCOPUS:0142119362

SN - 1351-5101

VL - 10

JO - European Journal of Neurology

JF - European Journal of Neurology

IS - 5

ER -

SCA2 and SCA3 mutations in young-onset dopa-responsive parkinsonism

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this